These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9924487)

  • 1. Growth-hormone-releasing factor for growth hormone deficiency.
    Med Lett Drugs Ther; 1999 Jan; 41(1043):2-3. PubMed ID: 9924487
    [No Abstract]   [Full Text] [Related]  

  • 2. [Growth hormone-releasing factor (GRF) in the treatment of the child with a growth hormone (GH) deficiency].
    Lanes R
    An Esp Pediatr; 1992 Jun; 36 Suppl 48():169-71. PubMed ID: 1636959
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnostic and therapeutic aspects of growth-hormone releasing factor].
    von Werder K; Losa M; Müller OA
    Internist (Berl); 1985 May; 26(5):259-65. PubMed ID: 3924850
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of treatment with human growth hormone in childhood].
    Job JC
    Bull Acad Natl Med; 1984; 168(5-6):543-7. PubMed ID: 6440663
    [No Abstract]   [Full Text] [Related]  

  • 5. [Growth hormone-releasing factor in Alzheimer's disease].
    Cacabelos R
    Med Clin (Barc); 1989 Mar; 92(8):299-301. PubMed ID: 2497286
    [No Abstract]   [Full Text] [Related]  

  • 6. The discovery of growth hormone-releasing hormone: an update.
    Thorner MO
    J Neuroendocrinol; 2008 Jun; 20(6):653-4. PubMed ID: 18601685
    [No Abstract]   [Full Text] [Related]  

  • 7. Growth hormone releasing factor may lower somatotropin demand.
    Ziporyn T
    JAMA; 1984 Sep; 252(10):1257-9. PubMed ID: 6433048
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience with GRF.
    Ranke MB
    Acta Paediatr Scand Suppl; 1986; 325():100-6. PubMed ID: 2884799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternatives to growth hormone.
    Lancet; 1989 Apr; 1(8642):820-2. PubMed ID: 2564906
    [No Abstract]   [Full Text] [Related]  

  • 10. Somatocrinin--growth hormone releasing factor--another hypothalamic hormone for clinical use.
    Romer TE; Rymkiewicz-Kluczyńska B; Szarras-Czapnik M
    Endokrynol Pol; 1987; 38(1):145-53. PubMed ID: 3123206
    [No Abstract]   [Full Text] [Related]  

  • 11. [A growth hormone releasing factor isolated, analysed, synthesized and already clinically tested in pediatrics].
    Jahreis G; Hesse V
    Kinderarztl Prax; 1984 Sep; 52(9):399-408. PubMed ID: 6438385
    [No Abstract]   [Full Text] [Related]  

  • 12. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?
    Walker RF
    Clin Interv Aging; 2006; 1(4):307-8. PubMed ID: 18046908
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacodynamic evaluation of a PEGylated analogue of human growth hormone releasing factor in rats and pigs.
    D'Antonio M; Louveau I; Esposito P; Bertolino M; Canali S
    Growth Horm IGF Res; 2004 Jun; 14(3):226-34. PubMed ID: 15125884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neurosecretory dysfunction of growth hormone].
    Barrio R; Fragoso J; Yturriaga R; Alonso M; Hernández M
    An Esp Pediatr; 1988 Oct; 29 Suppl 35():5-6. PubMed ID: 2908494
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of growth hormone treatment for ovulation induction.
    Katz E
    Curr Opin Obstet Gynecol; 1993 Apr; 5(2):234-9. PubMed ID: 8490094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the discovery of growth hormone-releasing hormone.
    Thorner MO
    Acta Paediatr Suppl; 1993 Mar; 388():2-7; discussion 8. PubMed ID: 8329827
    [No Abstract]   [Full Text] [Related]  

  • 17. Final height and growth hormone secretion after completion of growth hormone therapy in patients with idiopathic growth hormone deficiency and with abnormalities of the hypothalamic-pituitary region.
    Hilczer M; Smyczynska J; Stawerska R; Lewinski A
    Neuro Endocrinol Lett; 2005 Feb; 26(1):19-24. PubMed ID: 15726014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A brief review of the addition of gonadotropin-releasing hormone agonists (GnRH-Ag) to growth hormone (GH) treatment of children with idiopathic growth hormone deficiency: Previously published studies from America.
    Reiter EO
    Mol Cell Endocrinol; 2006 Jul; 254-255():221-5. PubMed ID: 16787696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
    Gonc EN; Kandemir N
    Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of panhypopituitarism].
    Vilardell Latorre E
    Med Clin (Barc); 1986 Apr; 86(15):636-40. PubMed ID: 3088344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.